Manage Your Liver
Q:

What is Hepatitis B?

A:

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). It can cause both acute and chronic disease. During the first six months, the hepatitis B infection is considered to be “acute”. If a person tests positive for HBV for more than six months, then they are diagnosed as having a chronic hepatitis B infection.


20-30% of adults who have chronic hepatitis B infection will develop cirrhosis and/or liver cancer.

 

And people who have hepatitis B surface antigen (HBsAg) in the blood for more than six months are consider to be hepatitis B carriers. The majority of these carriers have no symptoms, do not develop chronic hepatitis and do not require treatment.

 

Causes

The hepatitis B virus (HBV) is transmitted through contact with the blood, semen or other body fluids of an infected person. This can happen through sexual contact; sharing needles, syringes, or other drug-injection equipment; or from mother to baby at birth.

 

Signs and Symptoms

  • Nausea and vomiting
  • Dark urine (brown or orange)
  • Fatigue
  • Loss of appetite
  • Abdominal pain
  • Jaundice (yellowing of skin or whites of eyes)

 

Diagnosis

A number of blood tests are available to diagnose and monitor people with hepatitis B. They can be used to distinguish acute and chronic infections.

 

Liver Function Test

Liver function test measures the level of liver enzymes in the blood. In chronic hepatitis B patients, ALT (or SGPT) is the liver enzyme marker that is followed most closely. An elevated ALT level indicates that the liver might not be functioning properly and that there is a risk of liver damage.

 

Treatment

There is no specific treatment for acute hepatitis B. Treatment for chronic hepatitis B aims to reduce the risk of liver disease. Chronic hepatitis B infection can be treated with medicine. These are some common choices:

  • Interferons
  • Nucleoside reverse transcriptase inhibitors (NRTIs)

Unfortunately, in most people, treatment does not cure hepatitis B infection, but only slows down or stops the virus from multiplying. Therefore, most people who start treatment must continue for life. Also, in some people, interferon can cause a wide range of persistent and unpleasant side effects. This means that treatment may need to be withdrawn. The success rate of interferon for hepatitis B is around 20% to cure and 40% to stop liver damage.

 

Side Effects

Interferons have common side effects, including fever, headaches, and hair loss. They may also cause depression, difficulty breathing and chest tightness.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health. Multiple studies have demonstrated that the presence of an elevated ALT level is associated with increased liver-related mortality.   New normal ALT level issued The American College of Gastroenterology (ACG) recently issued a new Practice Guideline that aims to offer a framewor
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
Hit Questions
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us